{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:58:06Z","timestamp":1649102286723},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s10072-008-0905-6","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T08:31:26Z","timestamp":1213086686000},"page":"137-139","source":"Crossref","is-referenced-by-count":3,"title":["Treating headaches with botulinum toxin"],"prefix":"10.1007","volume":"29","author":[{"given":"Marco","family":"Aguggia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,11]]},"reference":[{"key":"905_CR1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000237336.65596.21","volume":"76","author":"A. Collins","year":"2006","unstructured":"Collins A, Jankovic J (2006) Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology 76:1083\u20131085","journal-title":"Neurology"},{"key":"905_CR2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1526-4610.2003.03115.x","volume":"43","author":"R.W. Ewans","year":"2003","unstructured":"Ewans RW, Blumenfeld A (2003) Botulinum toxin injections for headache. Headache 43:682\u2013685","journal-title":"Headache"},{"key":"905_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11940-002-0047-8","volume":"4","author":"N.T. Mathew","year":"2002","unstructured":"Mathew NT, Kaup AO (2002) The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol 4:365\u2013373","journal-title":"Curr Treat Options Neurol"},{"key":"905_CR4","first-page":"155","volume":"33","author":"L.L. Simpson","year":"1981","unstructured":"Simpson LL (1981) The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155\u2013188","journal-title":"Pharmacol Rev"},{"issue":"[Suppl1]","key":"905_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","volume":"248","author":"K.R. Aoki","year":"2001","unstructured":"Aoki KR (2001) Pharmacology and immunology of botulinum toxin serotypes. J Neurol 248[Suppl 1]:3\u201310","journal-title":"J Neurol"},{"key":"905_CR6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","volume":"59","author":"J. Purkiss","year":"2000","unstructured":"Purkiss J, Welch MKA, Doward S, Foster K (2000) Capsaicinstimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 59:1403\u20131406","journal-title":"Biochem Pharmacol"},{"key":"905_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","volume":"44","author":"P.L. Durham","year":"2004","unstructured":"Durham PL, Cady R, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44:35\u201343","journal-title":"Headache"},{"issue":"[Suppl1]","key":"905_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1468-1331.2006.01445.x","volume":"13","author":"W.J. Schulte-Mattler","year":"2006","unstructured":"Schulte-Mattler WJ, Martinez-Castrillo JC (2006) Botulinum toxin therapy of migraine and tension-type headache. Eur J Neurol 13[Suppl 1]:51\u201354","journal-title":"Eur J Neurol"},{"key":"905_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1526-4610.2003.03163.x","volume":"43","author":"A.M. Blumenfeld","year":"2003","unstructured":"Blumenfeld AM (2003) Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 43:853\u2013860","journal-title":"Headache"},{"key":"905_CR10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1526-4637.2006.00168.x","volume":"8","author":"J.R. Saper","year":"2007","unstructured":"Saper JR, Mathew NT, Loder EW et al (2007) A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine. Pain Med 8:478\u2013485","journal-title":"Pain Med"},{"key":"905_CR11","first-page":"749","volume":"44","author":"S. Tepper","year":"2004","unstructured":"Tepper S, Bigal M, Sheftell F, Rapoport A (2004) Botulinum neurotoxin type A in the preventive treatment of refractory headache. Headache 44:749\u2013800","journal-title":"Headache"},{"key":"905_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","volume":"45","author":"N. Mathew","year":"2005","unstructured":"Mathew N, Frishberg BM, Gawel et al (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache. Headache 45:293\u2013307","journal-title":"Headache"},{"key":"905_CR13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-2982.2004.00641.x","volume":"24","author":"W.G. Ondo","year":"2004","unstructured":"Ondo WG, Voung KD, Derman HS (2004) Botulinum toxin A for chronic daily headache. Cephalalgia 24:60\u201365","journal-title":"Cephalalgia"},{"key":"905_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","volume":"109","author":"W.J. Schulte-Mattler","year":"2004","unstructured":"Schulte-Mattler WJ, Krack P (2004) Treatment of chronic tension-type headache with botulinum toxin A. Pain 109:110\u2013114","journal-title":"Pain"},{"key":"905_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpneuro0639","volume":"3","author":"P. Goadsby","year":"2007","unstructured":"Goadsby P (2007) Emerging therapies for migraine. Nat Clin Pract Neurol 3:610\u2013619","journal-title":"Nat Clin Pract Neurol"},{"key":"905_CR16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","volume":"26","author":"J. Olesen","year":"2006","unstructured":"Olesen J, Bousser M-G, Diener H-C et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742\u2013746","journal-title":"Cephalalgia"},{"key":"905_CR17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/80.9.1126","volume":"80","author":"S.D. Silberstein","year":"2005","unstructured":"Silberstein SD, Stark SR, Lucas SM et al (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 80:1126\u20131137","journal-title":"Mayo Clin Proc"},{"key":"905_CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","volume":"45","author":"N.T. Mathew","year":"2005","unstructured":"Mathew NT, Frishberg BM, Gawel M et al (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45:293\u2013307","journal-title":"Headache"},{"key":"905_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4610.2005.05068.x","volume":"45","author":"D.W. Dodick","year":"2005","unstructured":"Dodick DW, Mauskop A, Elkind AH et al (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45:315\u2013324","journal-title":"Headache"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-0905-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0905-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:11:35Z","timestamp":1559106695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-0905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-0905-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}